| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/12/2007 | US7228723 Bumper impact-testing device |
| 06/12/2007 | CA2397772C Method for determining the response to cancer therapy |
| 06/12/2007 | CA2319699C Placental protein 13 |
| 06/12/2007 | CA2300913C Novel compound 2-amino-3-[2-(.alpha.-mannopyranosyl)indol-3-yl]propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound |
| 06/12/2007 | CA2276462C Multiplexed molecular analysis system apparatus and method |
| 06/12/2007 | CA2249410C Sigma-2 receptors as biomarkers of tumor cell proliferation |
| 06/12/2007 | CA2248772C Novel peptides which inhibit complement activation |
| 06/12/2007 | CA2148252C Interaction trap system for isolating novel proteins |
| 06/12/2007 | CA2143202C Elimination of false negatives in nucleic acid detection |
| 06/12/2007 | CA2113712C Papilloma virus vaccine |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/12/2007 | CA2046649C Matrix metalloproteinase inhibitor peptides |
| 06/09/2007 | CA2529677A1 Method of modulating gene transcription |
| 06/08/2007 | CA2539874A1 Novel uses of scleraxis |
| 06/07/2007 | WO2007065151A2 Differential immunoassay for prrs vaccine antibody |
| 06/07/2007 | WO2007064964A2 Methods of diagnosing inflammatory bowel disease |
| 06/07/2007 | WO2007064902A2 Mass spectrometry assays for acetyltransferase/deacetylase activity |
| 06/07/2007 | WO2007064859A2 Compound and method for suppressing retroviral replication |
| 06/07/2007 | WO2007064743A2 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 06/07/2007 | WO2007064720A2 Sour/acid taste receptor assays, genes and proteins |
| 06/07/2007 | WO2007064702A1 Real time binding analysis of antigens on a biosensor surface |
| 06/07/2007 | WO2007064462A1 Phage particle diagnostic reagents |
| 06/07/2007 | WO2007064355A2 Carbon nanotube-based glucose sensor |
| 06/07/2007 | WO2007064300A1 Electrochemical method of detecting an analyte |
| 06/07/2007 | WO2007064297A1 Nano scale reaction system |
| 06/07/2007 | WO2007064295A1 A system and method for determining a time when the blood alcohol concentration has passed a threshold level |
| 06/07/2007 | WO2007064294A1 Method for determining the quality of a biological sample |
| 06/07/2007 | WO2007064038A1 Detection of uterine leiomyosarcoma using lmp2 |
| 06/07/2007 | WO2007064022A1 Method for confirmation of nucleic acid preparation |
| 06/07/2007 | WO2007063982A1 Immunoagglutination assay for cell |
| 06/07/2007 | WO2007063825A1 Monoclonal antibody directed against cd166 and method for production thereof |
| 06/07/2007 | WO2007063736A1 Microarray chip, cell array using same and method for producing same |
| 06/07/2007 | WO2007063664A1 Vascular aging-predicting factor and utilization of the same |
| 06/07/2007 | WO2007063616A1 Ultrahighly sensitive determination reagent for c-reactive protein and determination method |
| 06/07/2007 | WO2007063423A1 Two step lateral flow assay methods and devices |
| 06/07/2007 | WO2007063363A2 Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2) |
| 06/07/2007 | WO2007063337A1 Apparatus for determining the presence of a contaminant in a sample of water or other fluid |
| 06/07/2007 | WO2007063333A1 Methods to monitor diagnose and identify biomarkers for psychotic disorders |
| 06/07/2007 | WO2007063326A2 Assay device and method |
| 06/07/2007 | WO2007063323A1 Sensor |
| 06/07/2007 | WO2007063316A2 Method for identifying a modulator of a cell signalling |
| 06/07/2007 | WO2007063312A1 Dog diabetes |
| 06/07/2007 | WO2007063174A1 Enrichment unit for biological components and an enrichment method |
| 06/07/2007 | WO2007063131A1 A generic assay for monitoring endocytosis |
| 06/07/2007 | WO2007063090A1 Polypeptide marker for the diagnosis and evaluation of ureteropelvic junction |
| 06/07/2007 | WO2007063089A2 Polypeptide marker for the diagnosis and evaluation of vascular diseases |
| 06/07/2007 | WO2007062931A1 Method for preparing the gases dissolved in liquids of high-voltage systems for external analysis, and device for carrying out said method |
| 06/07/2007 | WO2007062810A1 Mobile remote detection of fluids by a laser |
| 06/07/2007 | WO2007062789A1 Fibronectin as target/marker for insulin resistance |
| 06/07/2007 | WO2007062777A1 Methods and kits for breast cancer prognosis |
| 06/07/2007 | WO2007062728A1 Lateral-flow test device for liquid samples |
| 06/07/2007 | WO2007062719A2 Detection unit, in particular biosensor, and use thereof |
| 06/07/2007 | WO2007062676A1 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists |
| 06/07/2007 | WO2007062666A1 Fluidics device for assay |
| 06/07/2007 | WO2007062594A1 Neuregulin variants and methods of screening and using thereof |
| 06/07/2007 | WO2007062504A1 Light measurement automated zeroing and referencing system for a water quality analysis system |
| 06/07/2007 | WO2007062486A1 Methods for gene mapping and haplotyping |
| 06/07/2007 | WO2007047754A3 Mtor pathway theranostic |
| 06/07/2007 | WO2007047029A3 Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb) |
| 06/07/2007 | WO2007045432A9 Srf as a diagnostic and/or therapeutic target for diseases that are associated with neuronal abnormalities |
| 06/07/2007 | WO2007044438A3 Diagnosis and prevention of fetal heart disease |
| 06/07/2007 | WO2007043715A9 Rna-binding peptide |
| 06/07/2007 | WO2007038397A3 Molecular markers associated with bone metastasis |
| 06/07/2007 | WO2007036352A3 Chip for diagnosing the presence of candida |
| 06/07/2007 | WO2007033469A3 Liquid-phase galactose oxidase-schiff’s assay |
| 06/07/2007 | WO2007031657A3 Nanoporous direct optical transducing material for detecting aldehydes |
| 06/07/2007 | WO2007030748A3 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 06/07/2007 | WO2007028921A3 Method for detecting intracellular interaction between biomolecules |
| 06/07/2007 | WO2007028906A3 Method for assaying primary amines in very low concentration |
| 06/07/2007 | WO2007027353A3 Detection of proteases secreted from pathogenic microorganisms |
| 06/07/2007 | WO2007027234A3 Enzyme detection technique |
| 06/07/2007 | WO2007024763A3 Industrial field device with automatic indication of solids |
| 06/07/2007 | WO2007024676A3 Methods for preparing hybrid substrates comprising dna and antibodies and uses thereof |
| 06/07/2007 | WO2007024633A3 Multi-directional immunochromatographic assays |
| 06/07/2007 | WO2007021946A3 Silylamine modified nanoparticulate carriers |
| 06/07/2007 | WO2007017915A3 Use of common ϝ chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes. |
| 06/07/2007 | WO2007014267A3 Nanoparticle probes for capture, sorting and placement of targets |
| 06/07/2007 | WO2007005701A3 Gas phase chemical sensor based on film bulk acoustic resonators (fbar) |
| 06/07/2007 | WO2007005627A3 Tuberculosis antigen detection assays and vaccines |
| 06/07/2007 | WO2007004600A3 Target substance-capturing body, device for capturing target substance, and instrument, kit and method for detecting target substance by use of them |
| 06/07/2007 | WO2007002359A3 Methods for identifying delta subunit-containing gaba receptor modulatory agents |
| 06/07/2007 | WO2006138646A3 Protein profile for osteoarthritis |
| 06/07/2007 | WO2006137882A3 Reconfigurable protein patterning using electrowetting microelectrodes |
| 06/07/2007 | WO2006130806A3 Assay for agonists and antagonists of ion channels and for regulators of genetic expression |
| 06/07/2007 | WO2006128063A3 Methods and compositions for inhibiting glioma growth |
| 06/07/2007 | WO2006113245B1 Methods for measuring glycan levels of proteins |
| 06/07/2007 | WO2006112777A3 Uses of rhcc in drug delivery, real filtering, chemical catalysis and production of nanoparticles |
| 06/07/2007 | WO2006108094A3 Organ homing genes of cancer metastases |
| 06/07/2007 | WO2006107924B1 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 06/07/2007 | WO2006095086A3 Traceability of cellular cycle anomalies targeting oncology and neurodegeneration |
| 06/07/2007 | WO2006081331A3 Quinoxaline derivatives as antitumor agents |
| 06/07/2007 | WO2006071824A3 Isolation of cells or the like from bodily fluids |
| 06/07/2007 | WO2006058202A3 Mer diagnostic and therapeutic agents |
| 06/07/2007 | WO2006017700A3 Analyte filter method and apparatus |
| 06/07/2007 | WO2006017397A3 Methods and apparatus for intervertebral disc prosthesis insertion |
| 06/07/2007 | WO2005110079A3 Scent identification apparatus and method |
| 06/07/2007 | WO2005058937A3 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/07/2007 | WO2005052132A3 Mbms as modifiers of branching morphogenesis and methods of use |
| 06/07/2007 | WO2005047484A3 Biomarkers for alzheimer's disease |
| 06/07/2007 | WO2005037071A3 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |